Improving tobacco treatment for people living with HIV
Optimizing Tobacco Treatment Delivery for People Living with HIV
This study is looking at how to better help people with HIV quit smoking, since they tend to smoke more than others, by testing different ways to make tobacco treatment more effective and easier to access.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-11070288 on NIH RePORTER |
What this research studies
This research focuses on enhancing the delivery of tobacco treatment specifically for individuals living with HIV, who have higher smoking rates compared to the general population. It aims to evaluate and optimize evidence-based approaches, such as pharmacotherapy and behavioral counseling, to ensure these treatments effectively reach and engage patients. The study will explore proactive methods, including an opt-out approach for smoking cessation, to increase patient participation and improve outcomes. By assessing how these treatments are implemented in routine clinical care, the research seeks to identify the best strategies for helping patients quit smoking.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are current smokers and seeking assistance to quit.
Not a fit: Patients who are not living with HIV or who do not smoke may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce smoking rates and improve overall health outcomes for people living with HIV.
How similar studies have performed: Previous research has shown that proactive tobacco treatment approaches can effectively increase engagement and cessation rates, indicating a promising avenue for this study.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Rojewski, Alana — Medical University of South Carolina
- Study coordinator: Rojewski, Alana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.